Initial Success, Frequent RecurrenceByTomorrow’s Multiple Myeloma Treatments,the Value of Subtype AnalysisDecember 6th 2012Interview with David Siegel, MD, chief of the Division of Multiple Myeloma, John Theurer Cancer Center